Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema
ICD-10 E10.341 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema.
E10.341 refers to a specific complication of Type 1 diabetes mellitus characterized by severe nonproliferative diabetic retinopathy (NPDR) accompanied by macular edema. In this condition, the retinal blood vessels become damaged due to prolonged hyperglycemia, leading to leakage of fluid into the macula, which is critical for central vision. Patients may experience blurred vision, difficulty reading, and other visual disturbances. The severity of NPDR is determined by the extent of retinal changes, including microaneurysms, retinal hemorrhages, and exudates. Macular edema is a significant cause of vision loss in diabetic patients and requires careful monitoring and management. Treatment options may include laser therapy, intravitreal injections, and strict glycemic control to manage blood sugar levels effectively. Regular eye examinations are essential for early detection and intervention to prevent further complications.
Detailed retinal examination findings, visual acuity measurements, and treatment plans.
Patients presenting with blurred vision or sudden vision loss due to diabetic retinopathy.
Ensure that all findings are documented clearly to support the diagnosis and treatment provided.
Comprehensive diabetes management records, including HbA1c levels and insulin regimen.
Patients with poorly controlled diabetes presenting with complications.
Document the patient's overall diabetes management plan and any referrals made.
Used for treatment of diabetic retinopathy.
Document the indication for laser treatment and the extent of retinopathy.
Ophthalmologists should ensure that all treatment plans are well-documented.
Macular edema is a critical complication of diabetic retinopathy that can lead to significant vision loss. It occurs when fluid leaks into the macula, affecting central vision. Early detection and treatment are essential to prevent irreversible damage.
